Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.465 USD | -1.23% | -1.30% | -1.30% |
May. 14 | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
May. 13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.30% | 466M | |
+28.81% | 49.46B | |
+0.40% | 42.58B | |
+49.22% | 42.49B | |
-5.26% | 29.09B | |
+12.24% | 26.61B | |
-24.24% | 18.64B | |
+7.35% | 13.16B | |
+32.01% | 12.55B | |
+24.12% | 12.1B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Transcript : Voyager Therapeutics, Inc., Q4 2021 Earnings Call, Mar 08, 2022